Lifeward (NASDAQ:LFWD) Posts Earnings Results, Misses Estimates By $0.06 EPS

Lifeward (NASDAQ:LFWD) released its earnings results on Friday. The company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.06), Zacks reports. Lifeward had a negative return on equity of 137.91% and a negative net margin of 121.80%. Lifeward updated its FY 2025 guidance to EPS.

Lifeward Trading Up 14.9%

NASDAQ:LFWD traded up $0.08 during midday trading on Friday, hitting $0.60. 773,562 shares of the company were exchanged, compared to its average volume of 1,050,007. Lifeward has a fifty-two week low of $0.50 and a fifty-two week high of $4.00. The company has a market capitalization of $9.39 million, a PE ratio of -0.19 and a beta of 0.20. The company has a fifty day simple moving average of $0.65 and a 200 day simple moving average of $0.84.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Lifeward in a research report on Wednesday, October 8th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Lifeward currently has a consensus rating of “Moderate Buy” and an average target price of $9.00.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.